Global Fund-supported programmes’ contribution to international targets and the Millennium Development Goals: an initial analysis
Ryuichi Komatsu, Daniel Low-Beer, Bernhard Schwartländer
Volume 85, Number 10, October 2007, 805-811
Table 2. International targets and targets and results for Global Fund-supported programmes for ARV, DOTS and ITN
| Targets and results | People on ARV | DOTS detected | ITNs distributed (sub-Saharan Africa) |
|---|---|---|---|
| 3 million | 3.8 milliona | 69 millionb | |
| 384 000 | 1 million | 5.1 millionc | |
| 13% | 26% | 7% | |
| 544 000 | 1.4 million | 6.3 millionc | |
| 18% | 29% | 9% | |
| 8.3 million | 12 milliona | 76 millionb | |
| 1.6 million | 3.5 million | 64 millionc | |
| 19% | 28% | 84% |
ARV, people on antiretroviral treatment; DOTS, tuberculosis patients detected under the DOTS strategy; ITN, insecticide-treated nets distributed.a Estimated cumulative number of new sputum smear-positive cases detected under DOTS strategy since mid-2004.b Estimates based on 60% of the high-risk population in sub-Saharan Africa.c Figures for sub-Saharan Africa.d Results for Global Fund-supported programmes compared to estimated international targets for the corresponding period.Results for Global Fund-supported programmes may include deliveries that are co-financed by others. Sources and estimates based on 3,4,17,18,19 and Global Fund web site (http://www.theglobalfund.org).
